Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
alter decrease » water decreases (Expand Search), teer decrease (Expand Search), alter disease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
alter decrease » water decreases (Expand Search), teer decrease (Expand Search), alter disease (Expand Search)
-
841
-
842
-
843
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
844
-
845
-
846
-
847
Demographic characteristics of the breast cancer patients enrolled in the study.
Published 2025Subjects: -
848
-
849
-
850
-
851
-
852
The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).
Published 2025Subjects: -
853
-
854
The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.
Published 2025Subjects: -
855
Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.
Published 2025Subjects: -
856
The clinicopathological information of the patients involved in this study.
Published 2025Subjects: -
857
-
858
Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.
Published 2025Subjects: -
859
Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.
Published 2025Subjects: -
860